Table 2 Baseline characteristics of the study population
Characteristic | Risk of Malnutrition | p-value | ||||
|---|---|---|---|---|---|---|
Overall | Absent | Mild | Moderate | Severe | ||
(n = 12,898) | (n = 5093) | (n = 5984) | (n = 1703) | (n = 118) | ||
Demographic characteristics | ||||||
Age (years) | 63.9 ± 10.1 | 62.0 ± 9.9 | 64.5 ± 10.0 | 67.1 ± 10.0 | 67.8 ± 9.9 |  < 0.001 |
Female | 3852 (29.9) | 1755 (34.5) | 1638 (27.4) | 434 (25.5) | 25 (21.2) |  < 0.001 |
Medical history and Clinical condition | ||||||
T2DM | 12,115 (93.9) | 4782 (93.9) | 5623 ( 94.0) | 1598 ( 93.8) | 112 ( 94.9) | 0.968 |
T1DM | 12 (0.1) | 7 (0.1) | 4 (0.1) | 1 (0.1) | 0 (0.0) | 0.605 |
Anemia | 5066 (39.3) | 1221 (24.0) | 2513 (42.0) | 1228 (72.1) | 104 (88.1) |  < 0.001 |
Stroke | 995 (7.7) | 322 (6.3) | 469 (7.8) | 186 (10.9) | 18 (15.3) |  < 0.001 |
Hypertension | 8825 (68.4) | 3429 (67.3) | 4106 (68.6) | 1201 (70.5) | 89 (75.4) | 0.028 |
CKD | 3153 (24.4) | 789 (15.5) | 1476 (24.7) | 798 (46.9) | 90 (76.3) |  < 0.001 |
CHF | 1553 (12.0) | 379 (7.4) | 686 (11.5) | 435 (25.5) | 53 (44.9) |  < 0.001 |
AF | 388 (3.0) | 119 (2.3) | 180 (3.0) | 83 (4.9) | 6 (5.1) |  < 0.001 |
Dialysis history | 84 (0.7) | 6 (0.1) | 23 (0.4) | 40 (2.3) | 15 (12.7) |  < 0.001 |
AMI | 2361 (18.3) | 633 (12.4) | 1061 (17.7) | 616 (36.2) | 51 (43.2) |  < 0.001 |
Coronary vessels involvement | ||||||
Two-vessel disease | 128 (1.0) | 53 (1.0) | 65 (1.1) | 8 (0.5) | 2 (1.7) | 0.112 |
Three-vessel disease | 3365 (26.1) | 1230 (24.2) | 1572 (26.3) | 528 (31.0) | 35 (29.7) |  < 0.001 |
Four-vessel disease | 2 (0.0) | 1 (0.0) | 1 (0.0) | 0 (0.0) | 0 (0.0) | 0.952 |
Procedure | ||||||
PCI | 9748 (75.6) | 3793 (74.5) | 4517 (75.5) | 1344 (78.9) | 94 (79.7) | 0.002 |
Laboratory examination | ||||||
Albumin (g/L) | 36.18 ± 4.56 | 38.93 ± 2.70 | 35.83 ± 3.74 | 30.00 ± 3.86 | 24.54 ± 3.32 |  < 0.001 |
Lymphocyte(109/L) | 1.94 ± 0.72 | 2.25 ± 0.63 | 1.86 ± 0.68 | 1.36 ± 0.60 | 0.90 ± 0.38 |  < 0.001 |
TG (mmol/L) | 1.50 (1.10, 2.14) | 1.79 (1.32, 2.58) | 1.40 (1.03, 1.91) | 1.20 (0.92, 1.63) | 1.14 (0.89, 1.47) |  < 0.001 |
TC (mmol/L) | 4.45 ± 1.24 | 5.06 ± 1.08 | 4.11 ± 1.17 | 3.89 ± 1.18 | 3.41 ± 1.05 |  < 0.001 |
LDL-C(mmol/L) | 2.72 ± 0.96 | 3.14 ± 0.87 | 2.47 ± 0.91 | 2.35 ± 0.92 | 2.05 ± 0.81 |  < 0.001 |
HDL-C(mmol/L) | 0.95 ± 0.25 | 1.01 ± 0.24 | 0.93 ± 0.24 | 0.87 ± 0.25 | 0.75 ± 0.23 |  < 0.001 |
CREA(umol/L) | 88.10 (73.00, 110.43) | 82.53 (69.00, 99.00) | 89.10 (74.00,110.00) | 108.00 (83.00, 150.00) | 150.90 (104.00, 303.30) |  < 0.001 |
eGFR(ml/min/1.73m2) | 74.90 ± 28.34 | 81.50 ± 25.84 | 74.73 ± 27.38 | 60.31 ± 30.54 | 41.66 ± 27.63 |  < 0.001 |
hs-CRP (mg/L) | 4.45 ± 1.24 | 2.72 (1.04, 6.66) | 3.39 (1.04, 9.71) | 14.10 (3.65, 40.50) | 39.70 (12.92, 78.15) |  < 0.001 |
Hb (g/L) | 129.97 ± 18.18 | 135.77 ± 15.48 | 129.43 ± 16.99 | 116.48 ± 19.95 | 101.54 ± 22.11 |  < 0.001 |
HbA1c (%) | 7.88 ± 1.70 | 7.89 ± 1.65 | 7.86 ± 1.71 | 7.93 ± 1.80 | 7.78 ± 1.88 | 0.572 |
FBG (mmol/L) | 9.78 ± 4.62 | 9.52 ± 4.31 | 9.73 ± 4.69 | 10.57 ± 4.93 | 12.07 ± 6.61 |  < 0.001 |
2hPBG (mmol/L) | 12.83 ± 4.41 | 13.24 ± 4.39 | 12.67 ± 4.46 | 12.12 ± 4.12 | 11.09 ± 5.14 |  < 0.001 |
LVEF (%) | 57.73 ± 12.74 | 60.36 ± 11.45 | 57.37 ± 12.79 | 51.68 ± 13.76 | 49.67 ± 13.20 |  < 0.001 |
Treatment during hospitalization | ||||||
OADs | 7718 (61.1) | 3210 (63.5) | 3626 (61.9) | 838 (51.9) | 44 (42.3) |  < 0.001 |
ACEI/ARB | 5807 (46.0) | 2363 (46.8) | 2688 (45.9) | 714 (44.2) | 42 (40.4) | 0.193 |
β-blockers | 10,400 (82.3) | 4247 (84.1) | 4803 (82.0) | 1266 (78.3) | 84 (80.8) |  < 0.001 |
CCB | 3398 (26.9) | 1333 (26.4) | 1569 (26.8) | 458 (28.3) | 38 (36.5) | 0.062 |
Statins | 12,079 (95.6) | 4864 (96.3) | 5603 (95.6) | 1520 (94.1) | 92 (88.5) |  < 0.001 |
Aspirin | 11,623 (92.0) | 4697 (93.0) | 5393 (92.0) | 1450 (89.7) | 83 (79.8) |  < 0.001 |
Diuretic | 2203 (17.4) | 539 (10.7) | 986 (16.8) | 620 (38.4) | 58 (55.8) |  < 0.001 |